Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-X-C motif chemokine ligand 10 (CXCL10), historically known as Interferon-gamma inducible Protein 10kDa (IP-10), is a potent pro-inflammatory chemokine belonging to the CXC family. It is primarily secreted by various cell types, including monocytes, endothelial cells, and fibroblasts, in direct response to Interferon-gamma (IFN-g) (UniProt P02778). CXCL10 functions as a specific ligand for the G protein-coupled receptor CXCR3, which is predominantly expressed on Th1-type T cells, natural killer (NK) cells, and macrophages. This interaction is critical for the directed migration and recruitment of these immune cells to sites of infection and chronic inflammation (NCBI Gene ID: 3627). Beyond its role in leukocyte trafficking, CXCL10 also possesses angiostatic properties, allowing it to inhibit neovascularization. In clinical contexts, elevated levels of CXCL10 are associated with the pathogenesis of autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, making it a viable therapeutic target. Drugs like Eldelumab have been developed to neutralize CXCL10 to disrupt the cycle of chronic inflammatory cell recruitment (PMID: 25484347).
Monoclonal antibody neutralization of the chemokine ligand to prevent its interaction with the CXCR3 receptor, thereby inhibiting the recruitment of Th1-type inflammatory cells to diseased tissues (PMID: 25484347).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 10 (CXCL10) (CXCL10).